is an advanced and high-tech cancer gene testing technique.
Cancer is a genome disease, also known as a genetic mutation. Understanding this principle, we have successfully developed the OncoGS test to target gene mutations in Vietnamese cancer patients.
The test is intended to check most of the therapeutic mutations widely used by Vietnamese oncologists, licensed by the Food and Drug Administration (FDA) of the United States, and recommended by prestigious cancer organizations worldwide.
This test is developed for targeted therapy, which is an approach of using medications that only target the tumorigenesis mechanism with high therapeutic efficacy and fewer side effects than conventional treatments such as radiation therapy and chemotherapy.
Targeted therapy | Drugs |
---|---|
Lung cancer | Osimertinib, Afatinib, Mobocertinib, Alectinib, Lorlatinib |
Colorectal cancer | Cetuximab hoặc Panitumumab |
Breast cancer | Olaparib, Talazoparib |
Pancreatic cancer | Rucaparib |
Ovarian cancer | Niraparib, Olaparib |
GIST | Avapritinib, Imatinib |
(*) Điều trị đích được Cục thực phẩm và Dược phẩm Hoa Kỳ (FDA) phê duyệt
NO | Testing for cancer-associated genetic mutations | Testing genes |
---|---|---|
01 | Lung cancer | EGFR, KRAS, NRAS, BRAF, ALK-rearrangement, ROS1-rearrangement. |
02 | Colorectal cancer | KRAS, NRAS, BRAF, MLH1, MSH2 và MSH6 |
03 | Breast cancer/Ovarian/Pancreas | BRCA1, BRCA2, PIK3CA. |
04 | GIST | KIT, PDGFRA |
Copyright © 2020 GENE SOLUTIONS
Legal Representative: Nguyễn Hữu Nguyên
Enterprise No. 0314215140 – HCMC D.P.I issued on January 23, 2017
GET MEDICAL CONSULTATION FROM DOCTORS
Tư vấn di truyền